Court :
SEBI
Brief :
UNDER SECTION 15-I OF SECURITIES AND EXCHANGE BOARD OF INDIA ACT, 1992 READ WITH RULE 5 OF SEBI (PROCEDURE FOR HOLDING INQUIRY AND IMPOSING PENALTIES BY ADJUDICATING OFFICER) RULES, 1995.
Citation :
ADJUDICATION ORDERNo.: ORDER/AP/SK/2020-21/9141
BEFORE THE ADJUDICATING OFFICER
SECURITIES AND EXCHANGE BOARD OF INDIA
[ADJUDICATION ORDER No.: ORDER/AP/SK/2020-21/9141]
UNDER SECTION 15-I OF SECURITIES AND EXCHANGE BOARD OF INDIA ACT, 1992 READ WITH RULE 5 OF SEBI (PROCEDURE FOR HOLDING INQUIRY AND IMPOSING PENALTIES BY ADJUDICATING OFFICER) RULES, 1995.
______________________________________________________________________________
In respect of:
Ms. Girija Kelath
20th KM Hosur Road,
Electronics City,
Bangalore – 560100.
In the matter of Biocon Limited
1. Biocon Limited (hereinafter referred as “Biocon” or “the company”), is a company having its shares listed on BSE Ltd. (‘BSE’) and National Stock Exchange of India Ltd. (‘NSE’). Securities and Exchange Board of India ("SEBI") conducted investigation to ascertain whether there was any disclosure and code of conduct violation of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 (hereinafter referred to as “PIT Regulations”) by Ms. Girija Kelath (“Noticee”), a designated person of Biocon, with respect to her transactions during the period August 31, 2018 to October 01, 2018. Pursuant to the investigation, SEBI made the following observations:
a) The Company had closed the trading window from October 01, 2018 till October 27, 2018 (both days inclusive). The Compliance Officer of the Company vide email dated September 28, 2018 intimated the designated employees about the start date, end date of trading window closure as well as the date of opening of the trading window. The intimation, inter alia, stated the following:
To read more in details, find the enclosed file